PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
2.250
+0.020 (0.90%)
May 18, 2026, 4:00 PM EDT - Market closed
PetMed Express Revenue
PetMed Express had revenue of $40.66M in the quarter ending December 31, 2025, a decrease of -21.75%. This brings the company's revenue in the last twelve months to $186.96M, down -20.69% year-over-year. In the fiscal year ending March 31, 2025, PetMed Express had annual revenue of $226.97M, down -17.19%.
Revenue (ttm)
$186.96M
Revenue Growth
-20.69%
P/S Ratio
0.26
Revenue / Employee
$1,080,717
Employees
173
Market Cap
48.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 226.97M | -47.12M | -17.19% |
| Mar 31, 2024 | 274.10M | 26.53M | 10.71% |
| Mar 31, 2023 | 247.57M | -24.71M | -9.08% |
| Mar 31, 2022 | 272.28M | -31.30M | -10.31% |
| Mar 31, 2021 | 303.58M | 19.46M | 6.85% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 449.71B |
| Johnson & Johnson | 96.36B |
| Eli Lilly and Company | 72.25B |
| AbbVie | 62.82B |
| MDxHealth | 110.97M |
| Precipio | 25.83M |
| Metagenomi Therapeutics | 22.33M |
| Hyperion DeFi | 1.04M |
PETS News
- 26 days ago - PetMed Express partners with Rural King on pet pharmacy offering - TheFly
- 26 days ago - PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels - GlobeNewsWire
- 5 weeks ago - PetMed Express, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 3 months ago - PetMed Express Quarterly report: Q3 2026 - Filings
- 5 months ago - PetMed Express Quarterly report: Q2 2026 - Filings
- 5 months ago - PetMed Express Quarterly report: Q1 2026 - Filings
- 5 months ago - Cardone Ventures announces $4.25 per share proposal to acquire PetMed Express - TheFly
- 5 months ago - Cardone Ventures Announces Unsolicited $4.25 Per Share All-Cash Proposal to Acquire PetMed Express - Business Wire